hrsACE2
Human recombinant soluble ACE2.
General information
hrsACE2 is a formulation of human recombinant soluble ACE2 from CHO cells (Monteil et al., 2020).
Synonyms
Human recombinant soluble ACE2
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
RdRpol Protein factor Small molecule In vitro |
Vero E6 cells; kidney organoids | 10.28 | Reduces viral load in cell culture and kidney organoids, especially (at low doses) in combination with <a href= |
Nov/12/2020 |
|
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
Spike protein Spike variant Protein factor Viral vector In vitro Antibody |
293T cells; A549-ACE2 cells; BHK-21 cells; Vero cells; Huh-7 cells; Calu-3 cells; Caco-2 cells; (VSV) SARS-CoV-2 Spike pseudoviruses (B.1, Alpha, Beta, Gamma, Delta, or Omicron) | 41.58 | Soluble ACE2 inhibited SARS-CoV-2 (B.1, Delta, and Omicron) Spike pseudoviral cell entry in vitro. |
Dec/23/2021 |
AI-suggested references
| Link | Publication date |
|---|---|
|
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|
Apr/24/2020 |
